Home › Funds › RIVERBRIDGE PARTNERS LLC › GKOS

RIVERBRIDGE PARTNERS LLC position in GKOS

GLAUKOS CORP · Health Care

RIVERBRIDGE PARTNERS LLC reported holding 223,445 shares of GKOS (GLAUKOS CORP) in its Q3 2026 13F filing — a position valued at US$36.7M, representing 1.08% of its reported portfolio and ranking #29 among its reported holdings. RIVERBRIDGE PARTNERS LLC has disclosed GKOS holdings in 13 of the last 13 reported quarters, going back to Q3 2023.

Latest position (Q3 2026)223.44K sh
Reported value held$36.69M
Portfolio Weight1.08%
First reportedQ3 2023
Last changeReduce
Updated2026-11-13

Last updated: 2026-11-13 · Source: SEC EDGAR Form 13F-HR

How RIVERBRIDGE PARTNERS LLC's GKOS position evolved

RIVERBRIDGE PARTNERS LLC first disclosed a stake in GKOS in Q3 2023 at 558,487 shares (US$42.0M). The position peaked in Q3 2024 at 476,682 shares, worth US$62.1M. Across 13 filings, RIVERBRIDGE PARTNERS LLC increased the stake 2 time(s), trimmed it 10 time(s) and left it unchanged 0 time(s). The most recent filing (Q3 2026) shows 223,445 shares valued at US$36.7M — a reduction of -58,644 shares quarter over quarter.. Notable position changes include a 42% increase in Q2 2025 (shares fell 21% over the following quarter), a 41% increase in Q3 2025 (shares rose 38% over the following quarter), a 35% trim in Q2 2026 (shares rose 17% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q3 2023 558.49K $42.03M New
Q4 2023 548.14K $43.57M Reduce
Q1 2024 534.51K $50.40M Reduce
Q2 2024 493.07K $58.36M Reduce
Q3 2024 476.68K $62.10M Reduce
Q4 2024 312.93K $46.92M Reduce
Q1 2025 285.46K $28.10M Reduce
Q2 2025 403.97K $41.73M Add
Q3 2025 569.64K $46.45M Add
Q4 2025 535.17K $60.43M Reduce
Q1 2026 433.23K $46.64M Reduce
Q2 2026 282.09K $39.42M Reduce
Q3 2026 223.44K $36.69M Reduce

Dots on the line are colored by change type; missing quarters mean no position was reported.

About GKOS and 13F data

GKOS (GLAUKOS CORP) is a Health Care company. 45 other funds we track also report a position in GKOS — the largest reported positions include BRAIDWELL LP (US$82.7M), SUMMIT PARTNERS PUBLIC ASSET MANAGEMENT, LLC (US$62.4M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding GKOS

All GKOS fund holders →

FAQ

How long has RIVERBRIDGE PARTNERS LLC held GKOS?

RIVERBRIDGE PARTNERS LLC has disclosed GKOS holdings in 13 of the last 13 reported quarters, going back to Q3 2023.

What is RIVERBRIDGE PARTNERS LLC's current position in GKOS?

As of Q3 2026, RIVERBRIDGE PARTNERS LLC holds 223.44K shares of GKOS (GLAUKOS CORP), valued at $36.69M, representing 1.08% of its reported portfolio and ranking #29.

Has RIVERBRIDGE PARTNERS LLC been buying or selling GKOS?

In the latest 13F filing (Q3 2026), RIVERBRIDGE PARTNERS LLC reduced its position in GKOS. The position peaked in Q3 2024 at 476.68K shares.

Which other funds hold GKOS?

Other major institutional holders of GKOS include BRAIDWELL LP, SUMMIT PARTNERS PUBLIC ASSET MANAGEMENT, LLC, among 45 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.